Associations between clinical benefits of cancer drugs and incremental quality-adjusted life years used in reimbursement decisions in Australia, Canada, England and China: an observational study

Associations between clinical benefits of cancer drugs and incremental quality-adjusted life years used in reimbursement decisions in Australia, Canada, England and China: an observational study

Objectives To investigate the association between incremental quality-adjusted life years (QALYs) predicted in economic evaluations and clinical benefits assessed by the European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS), examining how accurately predicted QALYs re...

Full description

Saved in:
Bibliographic Details
Main Authors: Feng Xie, Dawei Zhu, Xiaodong Guan, Luwen Shi, Sheng Han, Yichen Zhang, Jinyu Chen, Kexin Han
Format: Article
Language:English
Published: BMJ Publishing Group 2025-08-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/8/e101678.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items